Page last updated: 2024-09-04

celastrol methyl ester and Triple Negative Breast Neoplasms

celastrol methyl ester has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dong, Y; Hu, P; Liu, S; Wang, J; Wang, RY; Wang, Y	1

Other Studies

1 other study(ies) available for celastrol methyl ester and Triple Negative Breast Neoplasms

Article	Year
Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3. Biomedical journal, 2021, Volume: 44, Issue:6 Suppl 1 Topics: Animals; Cadherins; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Integrin beta3; Mice; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms	2021

Article

Year

Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3.

Biomedical journal, 2021, Volume: 44, Issue:6 Suppl 1

Topics: Animals; Cadherins; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Integrin beta3; Mice; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms

2021